---
title: "Humanwell Healthcare Registers Multiple Sclerosis Drug"
date: "2025-02-11 10:45:57"
summary: "Humanwell Healthcare  obtained drug registration from China's drug administrator for dimethyl fumarate enteric-coated capsules. The drug is indicated for the treatment of relapsing multiple sclerosis, according to a Tuesday filing with the Shanghai bourse. Shares of the pharmaceutical company were down nearly 1% in recent trade."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Humanwell Healthcare obtained drug registration from China's drug administrator for dimethyl fumarate enteric-coated capsules.

The drug is indicated for the treatment of relapsing multiple sclerosis, according to a Tuesday filing with the Shanghai bourse.

Shares of the pharmaceutical company were down nearly 1% in recent trade.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250210:G2465959:0/)
